Loss of FBXO7 Protein Activity in Parkinson's Disease
Author Information
Author(s): Zhao Tianna, De Graaff Esther, Breedveld Guido J., Loda Agnese, Severijnen Lies-Anne, Wouters Cokkie H., Verheijen Frans W., Dekker Marieke C. J., Montagna Pasquale, Willemsen Rob, Oostra Ben A., Bonifati Vincenzo
Primary Institution: Erasmus MC, Rotterdam, The Netherlands
Hypothesis
Understanding the PARK15 pathogenesis might provide clues on the mechanisms of maintenance of brain dopaminergic neurons, which are lost in Parkinson's disease.
Conclusion
The common cellular abnormality found in PARK15 patients is the depletion of the FBXO7 isoform 1, which is crucial for the maintenance of brain neurons.
Supporting Evidence
- FBXO7 mutations were identified as the cause of PARK15, a juvenile parkinsonism.
- Two FBXO7 protein isoforms were confirmed to exist in normal human cells.
- FBXO7 isoform 1 is crucial for nuclear localization and stability of the protein.
- Patients with PARK15 showed a depletion of FBXO7 isoform 1 in their cells.
- FBXO7 is highly expressed in the nuclei of neurons in the human brain.
Takeaway
This study found that a protein called FBXO7 is important for brain cells, and when it doesn't work properly, it can lead to a type of Parkinson's disease.
Methodology
The study involved analyzing protein expression in cell lines from PARK15 patients and normal controls using Western blotting and immunofluorescence.
Limitations
The study was limited by the availability of patient-derived cell lines and the inability to obtain fibroblasts from all patients.
Participant Demographics
The study involved patients from Dutch and Italian families with PARK15 mutations.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website